Jodie Van Kley serves as Indiana Biosciences Research Institute’s (IBRI) top development and advancement leader. In her role, she cultivates and maintains relationships with major donors, expands business agreements, and oversees and manages all aspects of the IBRI’s fundraising programs.
Van Kley is a sales and brand strategist who partners with academia, industry leaders and biosciences entrepreneurs to expand the IBRI to support the delivery of translational science for patients suffering from the world’s most debilitating diseases.
Van Kley previously served in numerous commercial leadership roles at AstraZeneca Pharmaceuticals, including, sales leadership, market access and integrated health network strategic leadership positions. Prior to joining AstraZeneca, she worked for a private psychiatric hospital system focusing on business development, contracting and marketing strategies.